Ex-OpenAI CPO Kevin Weil launches Warp Sciences with $215M Series A for AI-driven drug discovery
josh_wills · x · 2026-10-23
Kevin Weil (ex-OpenAI CPO), DJ Patil, FAIR co-founder Manohar Paluri, and drug hunter Sol Reisberg launched Warp Sciences, raising a $215M Series A led by Lightspeed to apply AI and robotics to speed up medicine development. Warp is a US-based chemistry CRO pairing expert chemists with AI and automation-first labs. Angel backers include OpenAI CRO Mark Chen, CFO Sarah Friar, Dylan Field, Reid Hoffman, and Milan Kovac.
More from Venture
- AI surfaces broke SEO ROI modeling — execs must fund content without clear returns — gaganghotra_ · 2026-10-23
- AI stocks dip just ~3% despite 'Black Thursday' panic headlines — JensHonack · 2026-10-23
- Fewer than 1% of Black Friday purchases will be agentic, predicts SEO expert Gagan Ghotra — gaganghotra_ · 2026-10-23
- OpEra launches AI decision engines, cuts retailer delivery costs 38% — ycombinator · 2026-10-23
- AI x Bio's wild week: phages in a patient, 32-minute drug leads, OpenAI buys Orchestra Bio — HealthcareAIGuy · 2026-10-23
- Robot data startup Maxinsights raises $30M seed, launches tactile data glove MaxGlove — heyshrutimishra · 2026-10-23